Dare bioscience Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Dare bioscience Contact Number

Contact Us Daré Bioscience

8 hours ago Darebioscience.com Show details

858.926.7655We’d like to hear from you. We’d like to hear from you. 3655 Nobel Drive, Suite 260, San Diego, CA 92122. 858.926.7655. [email protected]

1. 3655 Nobel Dr Ste 260, San Diego, CA 92122 · (858) 926-7655DIRECTIONSWEBSITE

Category: Contact SupportShow more

Home Daré Bioscience

7 hours ago Darebioscience.com Show details

Menu Menu. Dare. To Be Bold. We’re driven by a mission to accelerate a diverse portfolio of novel therapies for women that expand treatment options, improve outcomes and facilitate convenience. Women's Health is our. Sole Focus. With …

Category: Home PhoneShow more

Dare Bioscience Crunchbase Company Profile & Funding

5 hours ago Crunchbase.com Show details

(858) 926-7655Founders Lisa Walters-Hoffert, Roger Hawley, Sabrina Martucci Johnson. Operating Status Active. Last Funding Type Grant. Stock Symbol NASDAQ:DARE. Company Type For Profit. Contact Email [email protected]darebioscience.com. Phone Number (858) 926-7655. Daré Bioscience is a healthcare company committed to the development and commercialization of

Founded: 2005

Category: Contact NumberShow more

Dare Bioscience Company Profile Office Locations

2 hours ago Craft.co Show details

Dare Bioscience has 9 employees at their 1 location. See insights on Dare Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Employees: 9
Type: Public
Founded: 2006
Location: 3655 Nobel Dr #260, San Diego, US

Category: Contact NumberShow more

Daré Bioscience Trademark Daré Bioscience, Inc. San

6 hours ago Bizapedia.com Show details

Daré Bioscience is a Trademark by Daré Bioscience, Inc., the address on file for this trademark is Suite 260 3655 Nobel Drive, San Diego, CA 92122

Category: Contact NumberShow more

DARE Dare Bioscience Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will deliver a company presentation at the H.C. Wainwright BIOCONNECT 2022 Conference being held virtually January 10 – 13, 2022.

Category: Contact NumberShow more

DARÉ BIOSCIENCE, INC. : Shareholders Board Members

Just Now Marketscreener.com Show details

Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing products for women’s health. Its portfolio of differentiated therapies expands treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility.

Category: Contact NumberShow more

Daré Bioscience, Inc. (DARE) Company Profile & Facts

5 hours ago Finance.yahoo.com Show details

See the company profile for Daré Bioscience, Inc. (DARE) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Category: Contact NumberShow more

Dare Bioscience, Inc. (Form: 8K, Received: 02/13/2018 16

3 hours ago Content.edgar-online.com Show details

125-18-0426DARÉ BIOSCIENCE, INC. (Exact name of registrant as specified in its charter) Delaware 001-36395 20-4139823 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 11119 North Torrey Pines Road, Suite 200 La Jolla, CA 92037 (Address of Principal Executive Offices and Zip Code) Registrant’s

Category: Contact NumberShow more

DARE Short Interest Dare Bioscience Inc Stock Short

8 hours ago Fintel.io Show details

DARE / Dare Bioscience Inc off-exchange short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short sales in various trading venues. For more information on how to interpret this data, read this information notice provided by FINRA.

Category: Contact NumberShow more

Contact D.A.R.E. America

5 hours ago Dare.org Show details

Contact D.A.R.E. for general questions or submit feedback (comments, questions, or complaints) about D.A.R.E. vendors.

Category: Contact SupportShow more

DARÉ BIOSCIENCE, INC. : DARE Stock Price US23666P1012

2 hours ago Marketscreener.com Show details

Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing products for women’s health. Its portfolio of differentiated therapies expands treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility.

Category: Contact NumberShow more

DARE Insider Trading Dare Bioscience Inc

7 hours ago Fintel.io Show details

019-05-16DARE. Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the first qu. 2019-05-16 sec.gov - a3318272releasepreviewpd Daré Bioscience Reports First Quarter

Category: Contact NumberShow more

Investors Daré Bioscience

Just Now Ir.darebioscience.com Show details

Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of …

Category: Contact NumberShow more

Dare Bioscience Inc (DARE) has fallen 6.57% Thursday In

2 hours ago Investorsobserver.com Show details

In the Biotechnology industry which is number 140 by this metric, DARE ranks better than 96% of stocks. Important Dates for Investors in DARE:-Dare Bioscience Inc is set to release earnings on 2/8/2022. During their last earnings release the company posted EPS of $-0.74. -We do not have a set dividend date for Dare Bioscience Inc at this time.

Category: Contact NumberShow more

Dare Bioscience Australia Pty Ltd ABN, ACN, Business

4 hours ago Aubiz.net Show details

013-05-22Dare Bioscience Australia Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2013-05-22 and was issued with the 163888097 ACN. Its Australian Business Number is 29163888097. Since 2015-10-09, the company is headquartered in VIC, post code 3006.

Category: Contact NumberShow more

Is Dare Bioscience Inc (DARE) a Good Buy in the

Just Now Investorsobserver.com Show details

A rating of 95 puts Dare Bioscience Inc near the top of the Biotechnology industry according to InvestorsObserver.Dare Bioscience Inc's score of 95 means it scores higher than 95% of stocks in the industry. Dare Bioscience Inc also received an overall rating of 65, putting it above 65% of all stocks.

Category: Contact NumberShow more

Daré Announces FDA Approval of XACIATO™ (clindamycin

Just Now Finance.yahoo.com Show details

SAN DIEGO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA

Category: Contact NumberShow more

DARE Stock Price Dare Bioscience Inc. Stock Quote (U.S

8 hours ago Marketwatch.com Show details

Dare Bioscience Gets FDA Priority Review of DARE-BV1 for Bacterial Vaginosis >DARE Aug. 9, 2021 at 8:42 a.m. ET Dare Bioscience stock rockets after new $49 million grant from Bill & Melinda Gates

Category: Contact NumberShow more

How to buy Daré Bioscience stock 21 Dec price $2.06

1 hours ago Finder.com Show details

Daré Bioscience is a biotechnology business based in the US. Daré Bioscience stocks (DARE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.34 – a decrease of 12.36% over the previous week. Daré Bioscience employs 16 staff and has a market cap (total outstanding stock value) of $134.8 million.

Category: Contact NumberShow more

Bayer and Daré Bioscience Announce Exclusive Licensing

9 hours ago Ir.darebioscience.com Show details

646-842-2299Source: Bayer and Daré Bioscience. Bayer Media: Sasha Damouni Ellis +1 646-842-2299 Email: [email protected] . Daré Bioscience, Inc. Investors: Lee Roth +1 212-213-0006 Burns McClellan Email: [email protected] . OR. Media Jake Robison +1 619-849-5383 Canale Communications Email: [email protected]

Category: Contact NumberShow more

DARE Stock Dare Bioscience, Inc. SEC Filings

Just Now Sec.report Show details

Dare Bioscience Inc is a clinical-stage biopharmaceutical company focused on women's reproductive health. The products of the company are related to fertility, vaginal health, and contraception. Ovaprene is a product designed by the company to provide multiple weeks of contraceptive protection without the use of hormones. DARE BIOSCIENCE, INC.

Category: Contact NumberShow more

Daré Bioscience Announces FDA Acceptance and Priority

9 hours ago Globenewswire.com Show details

Daré Bioscience Announces FDA Acceptance and Priority Review of New Drug Application for DARE-BV1 for the Treatment of Bacterial Vaginosis. Six-month priority review granted for DARE-BV1 with

Category: Contact NumberShow more

DARE Insider Trading Dare Bioscience, Inc. Form 4 SEC

2 hours ago Secform4.com Show details

Insider Trading - Dare Bioscience, Inc. (. DARE. ) Real time insider trading transaction history: Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares. "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the

Category: Contact NumberShow more

SEC FORM D

4 hours ago Sec.gov Show details

858-769-9145Dare Bioscience, Inc. Street Address 1 Street Address 2; 11119 NORTH TORREY PINES ROAD: SUITE 200: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; LA JOLLA: CALIFORNIA: 92037: 858-769-9145

Category: Contact NumberShow more

Daré Bioscience, Inc. (DARE) Company Profile & Facts

8 hours ago Ca.finance.yahoo.com Show details

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women's health in the United States. The company develops therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel

Category: Contact NumberShow more

DARE Stock Forecast, Price & News (Daré Bioscience)

6 hours ago Marketbeat.com Show details

3 equities research analysts have issued 1-year price objectives for Daré Bioscience's shares. Their forecasts range from $5.00 to $11.00. On average, they expect Daré Bioscience's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 381.9% from the stock's current price.

Category: Contact NumberShow more

Dare Bioscience Price Forecast Naive Prediction DARE

9 hours ago Macroaxis.com Show details

Dare Bioscience Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Dare Bioscience historical stock prices and determine the direction of Dare Bioscience's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading.

Category: Contact NumberShow more

Dare Bioscience Inc (DARE) Stock Price & News Google Finance

8 hours ago Google.com Show details

Get the latest Dare Bioscience Inc (DARE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Category: Contact NumberShow more

Daré Bioscience, Inc. (NASDAQ:DARE) Short Interest Update

2 hours ago Marketbeat.com Show details

Daré Bioscience, Inc. (NASDAQ:DARE) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 6,060,000 shares, an increase of 227.6% from the November 30th total of 1,850,000 shares. Based on an average daily volume of 5,300,000 shares, the days-to-cover ratio is presently 1.1 days.

Category: Contact NumberShow more

Jobs with DARÉ Bioscience BioSpace

7 hours ago Biospace.com Show details

89 articles with DARÉ Bioscience. Daré Bioscience to Participate in H.C. Wainwright BIOCONNECT 2022 Conference. 1/4/2022. Daré Bioscience, Inc., a leader in women’s health innovation, announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will deliver a company presentation at the H.C. Wainwright BIOCONNECT …

Category: Contact NumberShow more

Daré Bioscience to Host Third Quarter 2021 Financial

Just Now Biospace.com Show details

The conference ID number for the replay is 8459303. The call and webcast replay will be available until November 24, 2021. About Daré Bioscience. Daré Bioscience is a clinical-stage biopharmaceutical company committed to advancing innovative products for …

Category: Contact NumberShow more

Daré Bioscience Announces FDA Acceptance and Priority

6 hours ago Drugs.com Show details

SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) accepted for filing the company’s New Drug Application (NDA) for DARE-BV1 for the treatment of bacterial vaginosis.

Category: Contact NumberShow more

Lincoln Park Capital Fund Investments, Portfolio

4 hours ago Crunchbase.com Show details

Lincoln Park Capital Fund has made 2 diversity investments. Their most recent diversity investment was on Jun 8, 2021, when Ocuphire Pharma raised $15M. Lincoln Park Capital Fund has had 19 exits. Lincoln Park Capital Fund 's most notable exits include X4 Pharmaceuticals , Cyclerion Therapeutics , and Dare Bioscience.

Category: Contact NumberShow more

Buy Dare Bioscience Stock DARE Stock Price & Latest News

Just Now Public.com Show details

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is

Category: Contact NumberShow more

Statement of Ownership (sc 13g)

1 hours ago Ih.advfn.com Show details

Name of issuer: Dare Bioscience Inc. Title of Class of Securities: Common Stock. CUSIP Number: 23666P101. Date of Event Which Requires Filing of this Statement: December 31, 2020. Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d)

Category: Contact NumberShow more

Cerulean Pharma Company Profile: Acquisition & Investors

7 hours ago Pitchbook.com Show details

Description. Developer of nanoparticle-drug conjugates designed to target tumors, reduce toxicity, and enable combinations. The products of the company are related to fertility, vaginal health, and contraception. Ovaprene is a product designed by the company to provide multiple weeks of contraceptive protection without the use of hormones.

Category: Contact NumberShow more

DARE 13F Hedge Fund and Asset Management Owners

4 hours ago Whalewisdom.com Show details

858-769-91459. 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA, CA 92037. 858-769-9145. www.ceruleanrx.com. Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals.

Category: Contact NumberShow more

Is Dare Bioscience Stock a good investment? DARE 1.56 0

2 hours ago Macroaxis.com Show details

Dare Bioscience is trading at 1.56 as of the 13th of January 2022, a -7.69 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.56. Get the latest Dare Bioscience detailed stock quotes, stock trade data, stock price info, and performance analysis, including Dare Bioscience Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

5 Penny Stocks to Buy in December Insider Monkey

7 hours ago Insidermonkey.com Show details

Number of Hedge Fund Holders: 3 . Daré Bioscience, Inc. (NASDAQ:DARE) is a clinical-stage biopharma firm focusing on products related to the health of women.

Category: Contact NumberShow more

A novel intravaginal ring technology featuring the

6 hours ago Sbir.gov Show details

treatment options for women having one or both clinical risk factors for a preterm birth, Daré Bioscience is advancing the development of a novel intravaginal ring, called DARE-FRT1. DARE-FRT1 offers women a patient-friendly, extended-release progesterone product that delivers a relatively constant level of the drug in

Category: Tech SupportShow more

Current Report Filing (8k)

7 hours ago Ih.advfn.com Show details

DARE Dare Bioscience Inc Current Report Filing (8-k) On December 7, 2021, the U.S. Food and Drug Administration ("FDA") approved the New Drug Application for DARE-BV1, trade name XACIATO TM [zah-she-AH-toe] (clindamycin phosphate vaginal gel, 2%), for the treatment of bacterial vaginosis in female patients 12 years of age and older. XACIATO is a clear, …

Category: Contact NumberShow more

Dare Bioscience, Inc. Common Stock (DARE) Insider Activity

7 hours ago Nasdaq.com Show details

Dare Bioscience, Inc. Common Stock (DARE) Nasdaq Listed. Nasdaq 100. $1.48. -0.04 (-2.63%) CLOSED AT 4:00 PM ET ON Oct 21, 2021. Data is currently not available. $1.47.

Category: Contact NumberShow more

DARE Dare Bioscience Inc. Analyst Estimates MarketWatch

5 hours ago Marketwatch.com Show details

Advanced Charting. 1D 5D 1M 3M 6M YTD 1Y 3Y All Range Dropdown. Volume: 3.35M 65 Day Avg: 2.21M. 152% vs Avg. 1.6500 Day Range 1.8000. 1.1000 52 Week Range 3.8500.

Category: Contact NumberShow more

Insider Trading Activities at Dare Bioscience, Inc. (CERU)

5 hours ago Insider-monitor.com Show details

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dare Bioscience, Inc. (CERU) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dare Bioscience, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1401914.

Category: Contact NumberShow more

DARE Stock News DARE BIOSCIENCE Stock Price Today

3 hours ago Markets.businessinsider.com Show details

DARE: Get the latest Dare Bioscience stock price and detailed information including DARE news, historical charts and realtime prices. Number of Shares. 1.56 Day Low. 1.69 Contact Us!

Category: Contact NumberShow more

Exhibit SEC

6 hours ago Sec.gov Show details

This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of April 22, 2020, by and between DARÉ BIOSCIENCE, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”).Capitalized terms used herein and not otherwise defined herein shall …

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What does Daré Bioscience do?

About Daré Bioscience Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health.

How do I contact dardaré Bioscience?

Daré Bioscience's mailing address is 3655 NOBEL DRIVE SUITE 260, SAN DIEGO CA, 92122. The biotechnology company can be reached via phone at (858) 926-7655, via email at [email protected], or via fax at 617-494-1544. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.

When is Daré Bioscience's next quarterly announcement?

Daré Bioscience is scheduled to release its next quarterly earnings announcement on Tuesday, March 29th 2022. View our earnings forecast for Daré Bioscience. How were Daré Bioscience's earnings last quarter?

What is Daré Bioscience's short-interest ratio?

Based on an average daily trading volume, of 2,240,000 shares, the short-interest ratio is presently 0.8 days. View Daré Bioscience's Short Interest. When is Daré Bioscience's next earnings date?

Popular Brands

Daikin
Denso
Demant
Dsv
Dlf
Dbs
Dsm
Dana